Table 1 Comparison of characteristics of patients with HCC, CHB and healthy control in training and validation sets.
From: A Simple Noninvasive Index Can Predict Hepatocellular Carcinoma in Patients with Chronic Hepatitis B
Variables | Training Set (n = 224) | Validation Set (n = 239) | ||||
|---|---|---|---|---|---|---|
HCC (n = 76) | Healthy (n = 95) | CHB (n = 53) | HCC (n = 92) | Healthy (n = 69) | CHB (n = 78) | |
Gender | ||||||
    Male (%) | 58 (76) | 58 (61) | 40 (75) | 75 (82) | 54 (78) | 61 (78) |
    Female (%) | 18 (24) | 37 (39) | 13 (25) | 17 (18) | 15 (22) | 17 (22) |
Age, years | 57 ± 9 | 45 ± 10 | 46 ± 14 | 58 ± 8 | 53 ± 13 | 39 ± 12 |
White cell count (×109/L) | 5.0 ± 2.0 | 6.2 ± 1.5 | 5.7 ± 2.4 | 4.4 ± 2.1 | 6.3 ± 1.1 | 5.9 ± 2.1 |
Red blood count (×1012/L) | 4.3 ± 0.8 | 5.0 ± 0.5 | 4.5 ± 0.7 | 4.3 ± 0.8 | 5.0 ± 0.5 | 4.7 ± 0.7 |
Platelet count (×109/L) | 132 ± 73 | 251 ± 51 | 165 ± 82 | 121 ± 67 | 250 ± 50 | 169 ± 64 |
Lymphocyte (×109/L) | 1.3 ± 0.7 | 2.3 ± 0.7 | 1.7 ± 0.6 | 1.2 ± 0.6 | 2.1 ± 0.4 | 1.8 ± 0.6 |
Monocyte (×109/L) | 0.4 ± 0.2 | 0.4 ± 0.1 | 0.5 ± 0.3 | 0.4 ± 0.2 | 0.4 ± 0.1 | 0.5 ± 0.2 |
Neutrophil (×109/L) | 3.1 ± 1.5 | 3.3 ± 1.1 | 3.3 ± 2.0 | 2.7 ± 1.8 | 3.5 ± 1.0 | 3.4 ± 2.0 |
AFP (ng/ml) | 372.6 ± 475.9 | 3.2 ± 1.6 | 94.4 ± 177.0 | 423.1 ± 645.9 | 3.4 ± 2.0 | 136.7 ± 260.6 |
AST (U/L) | 82 ± 114 | 21 ± 7 | 316 ± 319 | 68 ± 110 | 24 ± 10 | 277 ± 277 |
ALT (U/L) | 67 ± 101 | 22 ± 13 | 525 ± 716 | 49 ± 41 | 24 ± 18 | 474 ± 439 |
GGT (U/L) | 147 ± 202 | 33 ± 23 | 129 ± 97 | 111 ± 134 | 30 ± 17 | 155 ± 157 |
ALP (U/L) | 145 ± 74 | 83 ± 21 | 121 ± 61 | 148 ± 94 | 85 ± 21 | 131 ± 52 |
TBIL (umol/L) | 37.1 ± 62.0 | 13.7 ± 5.8 | 104.8 ± 126.6 | 34.2 ± 40.1 | 15.6 ± 6.2 | 98.2 ± 124.0 |
BCLC stages | ||||||
    0 (%) | 5 (7) |  |  | 11 (12) |  |  |
    A (%) | 18 (24) |  |  | 25 (27) |  |  |
    B (%) | 23 (30) |  |  | 26 (28) |  |  |
    C (%) | 30 (39) |  |  | 29 (32) |  |  |
    D (%) | 0 (0) |  |  | 1 (1) |  |  |
